Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

INMB Q2 2017 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena

INMBINmune Bio, Inc.

$38M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$165,000

Net Income

-$165,000

EPS (Diluted)

$-0.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$87,812

Free Cash Flow

-$87,812

Stock-Based Comp.

$36,922

← FY 2017 All Quarters Q3 2017 →